|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||40.26 - 46.10|
|52 Week Range||29.12 - 80.95|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||11.51|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for CALXLearn more
Cowen analyst Paul Silverstein says Calix Inc's (NYSE: CALX) "solid beat and raises" in Q4 would have been meaningfully better if not for supply chain issues. Calix reported fourth-quarter FY21 revenue of $176.4 million above the consensus of $173.9 million. Adjusted EPS of $0.26 beat the consensus of $0.24. Calix sees Q1 FY22 revenue of $174 million - $180 million above the consensus of $164.2 million. Calix sees adjusted EPS of $0.16 - $0.21, above the consensus of $0.15. The issue reinforces
Calix (CALX) delivered earnings and revenue surprises of 8.33% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Bethesda, MD, based Investment company Macroview Investment Management Llc (Current Portfolio) buys Vanguard High Dividend Yield Indx ETF, iShares MSCI EAFE ETF, SPDR Biotech ETF, Microsoft Corp, iShares MSCI Emerging Markets ETF, sells Semler Scientific Inc, Janus Henderson Short Duration Income ETF, PIMCO Enhanced Short Maturity Active Exchange-Trad, iShares Core U.S.